Connor, Clark & Lunn Investment Management Ltd. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$638,959
-17.5%
591,629
-1.5%
0.00%
-25.0%
Q2 2023$774,756
+0.6%
600,586
+2.9%
0.00%0.0%
Q1 2023$770,079
-10.4%
583,393
+1.9%
0.00%
-20.0%
Q4 2022$859,187
+3204.6%
572,791
+5549.9%
0.01%
Q3 2017$26,000
-92.6%
10,138
-92.1%
0.00%
-100.0%
Q2 2017$349,000
-50.4%
127,923
-39.8%
0.00%
-60.0%
Q1 2017$704,000
+28.0%
212,651
-8.0%
0.01%
+25.0%
Q4 2016$550,000
-53.2%
231,144
-27.8%
0.00%
-50.0%
Q3 2016$1,176,000
+22.8%
320,344
-25.4%
0.01%
+14.3%
Q2 2016$958,000
+7.3%
429,5440.0%0.01%0.0%
Q1 2016$893,000
-36.0%
429,544
-6.8%
0.01%
-41.7%
Q4 2015$1,396,000
+40.4%
460,672
+14.5%
0.01%
+50.0%
Q3 2015$994,000
+25.5%
402,450
+63.2%
0.01%
+14.3%
Q2 2015$792,000
+52.6%
246,600
+69.6%
0.01%
+75.0%
Q1 2015$519,000
+1107.0%
145,400
+661.3%
0.00%
Q4 2014$43,000
-53.8%
19,100
-11.6%
0.00%
-100.0%
Q1 2014$93,00021,6180.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders